Applications of artificial intelligence to drug design and discovery in the big data era: a comprehensive review
Tóm tắt
Từ khóa
Tài liệu tham khảo
Ashburn TT, Thor KB (2004) Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3:673–683. https://doi.org/10.1038/nrd1468
DiMasi JA, Grabowski HG, Hansen R (2016) Innovation in the pharmaceutical industry: new estimates of R&D costs. J Health Econ 47:20–33. https://doi.org/10.1016/j.jhealeco.2016.01.012
Silver D, Hubert T, Schrittwieser J, Antonoglou I, Lai M, Guez A, Lanctot M, Sifre L, Kumaran D, Graepel T, Lillicrap T, Simonyan K, Hassabis D (2018) A general reinforcement learning algorithm that masters chess, shogi, and Go through self-play. Science 362:1140–1144. https://doi.org/10.1126/science.aar6404
Ma C, Wang L, Xie XQ (2011) GPU accelerated chemical similarity calculation for compound library comparison. J Chem Inf Model 51(7):1521–2152. https://doi.org/10.1021/ci1004948
Smalley E (2017) AI-powered drug discovery captures pharma interest. Nat Biotechnol 35:604–605. https://doi.org/10.1038/nbt0717-604
Mak KK, Pichika MR (2019) Artificial intelligence in drug development: present status and future prospects. Drug Discovery Today 24(3):773–780. https://doi.org/10.1016/j.drudis.2018.11.014
Domingos P, Pazzani M (1997) On the optimality of the simple Bayesian classifier under zero-one loss. Mach Learn 29:103–130. https://doi.org/10.1023/A:1007413511361
Cox DR (1958) The regression analysis of binary sequences. J R Stat Soc B 20:215–242. https://www.jstor.org/stable/2983890.
Hou TJ, Wang JM, Li YY (2007) ADME evaluation in drug discovery. 8. The prediction of human intestinal absorption by a support vector machine. J Chem Inf Model 47:2408–2415. https://doi.org/10.1021/ci7002076
Svetnik V, Liaw A, Tong C (2003) Random forest: a classification and regression tool for compound classification and QSAR modeling. J Chem Inf Comput Sci 43:1947–1958. https://doi.org/10.1021/ci034160g
Rayhan F, Ahmed S, Shatabda S, Farid DM, Mousavian Z, Dehzangi A, Rahman MS (2017) iDTI-ESBoost, Identification of drug target interaction using evolutionary and structural features with boosting. Sci Rep 7:17731. https://doi.org/10.1038/s41598-017-12580-2
Cao DS, Xu QS, Liang YZ, Chen XA, Li HD (2010) Automatic feature subset selection for decision tree-based ensemble methods in the prediction of bioactivity. Chemometr Intell Lab 103(2):129–136. https://doi.org/10.1016/j.chemolab.2010.06.008
Lavecchia A, Di Giovanni C (2013) Virtual screening strategies in drug discovery: a critical review. Curr Med Chem 20:2839–2860. https://doi.org/10.2174/09298673113209990001
Vanhaelen Q, Mamoshina P, Aliper AM, Artemov A, Lezhnina K, Ozerov I, Labat I, Zhavoronkov A (2017) Design of efficient computational workflows for in silico drug repurposing. Drug Discov Today 22:210–222. https://doi.org/10.1016/j.drudis.2016.09.019
Schmidhuber J (2015) Deep learning in neural networks an overview. Neural Netw 61:85–117. https://doi.org/10.1016/j.neunet.2014.09.003
Sheridan RP (2013) Time-split cross-validation as a method for estimating the goodness of prospective prediction. J Chem Inf Model 53(4):783–790. https://doi.org/10.1021/ci400084k
Wu Z, Ramsundar B, Feinberg EN, Gomes J, Geniesse C, Pappu AS, Leswing K, Pande V (2018) MoleculeNet: a benchmark for Molecular Machine Learning. Chem Sci 9:513–530. https://doi.org/10.1039/C7SC02664A
Minnich AJ, McLoughlin K, Tse M, Deng J, Weber A, Murad N, Madej BD, Ramsundar B, Rush T, Calad-Thomson S, Brase J, Allen JE (2020) AMPL: a data-driven modeling pipeline for drug discovery. J Chem Inf Model 60:1955–1968. https://doi.org/10.1021/acs.jcim.9b01053
Mayr A, Klambauer G, Unterthiner T, Steijaert M, Wegner JK, Ceulemans H, Clevert D-A, Hochreiter S (2018) Large-scale comparison of machine learning methods for drug target prediction on ChEMBL. Chem Sci 9:5441–5451. https://doi.org/10.1039/C8SC00148K
Zhong FS, Xing J, Li XT, Liu XH, Fu ZY, Xiong ZP, Lu D, Wu XL, Zhao JH, Tan XQ, Li F, Luo XM, Li XZ, Chen KX, Zheng MY, Jiang HL (2018) Artificial intelligence in drug design. Sci China Life Sci 61:59–72. https://doi.org/10.1007/s11427-018-9342-2
Jing YK, Bian YM, Hu ZH, Wang LR, Sean Xie XQ (2018) Deep learning for drug design: an artificial intelligence paradigm for drug discovery in the big data era. AAPS J 20:58. https://doi.org/10.1208/s.12248-018-0210-0
Sze V, Chen YH, Yang T, Emer JS (2017) Efficient processing of deep neural networks: a tutorial and survey. Proc IEEE 105:2295–2329. https://doi.org/10.1109/JPROC.2017.2761740
Yang Y, Adelstein SJ, Kassis AI (2009) Target discovery from data mining approaches. Drug Discov Today 2(14):147–154. https://doi.org/10.1016/j.drudis.2008.12.005
Chan HCS, Shan H, Dahoun T, Vogel H, Yuan S (2019) Advancing drug discovery via artificial intelligence. Trends Pharmacol Sci 40(8):592–604. https://doi.org/10.1016/j.tips.2019.06.004
Ciallella HL, Zhu H (2019) Advancing computational toxicology in the big data era by artificial intelligence: data-driven and mechanism-driven modeling for chemical toxicity. Chem Res Toxicol 32:536–547. https://doi.org/10.1021/chemrestox.8b00393
Brown N (2015) In silico medicinal chemistry: computational methods to support drug design. Royal Society of Chemistry. https://doi.org/10.1039/9781782622604
Kumar R, Chaudhary K, Gupta S, Singh H, Kumar S, Gautam A, Kapoor P, Raghava GPS (2013) CancerDR: cancer drug resistance database. Sci Rep 3:1445. https://doi.org/10.1038/srep01445
Kim S, Thiessen PA, Bolton EE, Chen J, Fu G, Gindulyte A, Han L, He J, He S, Shoemaker BA, Wang J, Yu B, Zhang J, Bryant SH (2016) Pubchem substance and compound databases. Nucleic Acids Res 44:D1202–D1213. https://doi.org/10.1093/nar/gkv951
Placzek S, Schomburg I, Chang A, Jeske L, Ulbrich M, Tillack J, Schomburg D (2017) BRENDA in 2017: new perspectives and new tools in BRENDA. Nucleic Acids Res 45:D380–D388. https://doi.org/10.1093/nar/gkw952
Chen R, Liu X, Jin S, Lin J, Liu J (2018) Machine learning for drug-target interaction prediction. Molecules 23:2208. https://doi.org/10.3390/molecules23092208
Gaulton A, Bellis LJ, Bento AP, Chambers J, Davies M, Hersey A, Light Y, Mcglinchey S, Michalovich D, Allazikani B (2012) ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res 40:D1100–D1107. https://doi.org/10.1038/srep01445
Magariños MP, Carmona SJ, Crowther GJ, Ralph SA, Roos DS, Shanmugam D, Voorhis WCV, Agüero F (2012) TDR targets: a chemogenomics resource for neglected diseases. Nucleic Acids Res 40:D1118–D1127. https://doi.org/10.1093/nar/gkr1053
Günther S et al (2008) SuperTarget and Matador: resources for exploring drug-target relationships. Nucleic Acids Res 36:D919–D922. https://doi.org/10.1039/nar/gkm862
Russell SJ, Norvig P (2003) Artificial intelligence: a modern approach. Upper Saddle River, NJ: Prentice Hall/Pearson Ed.
Hansch C, FujitaT, (1964) ρ-σ-π Analysis. a method for the correlation of biological activity and chemical structure. J Am Chem Soc 86:1616–1626. https://doi.org/10.1021/ja01062a035
Zefirov NS, Palyulin VA (2002) Fragmental approach in QSPR. J Chem Inform Comput Sci 42:1112–1122. https://doi.org/10.1021/ci020010e
McGregor MJ, Muskal SM (1999) Pharmacophore fingerprinting. 1. application to QSAR and focused library design. J Chem Inf Comput Sci 39:569–577. https://doi.org/10.1021/ci980159j
Gozalbes R, Doucet JP, Derouin F (2002) Application of topological descriptors in QSAR and drug design: history and new trends. Curr Drug Targets Infect Disord 2:93–102. https://doi.org/10.2174/1568005024605909
Zhu H (2020) Big data and artificial intelligence modeling for drug discovery. Annu Rev Pharmacol Toxicol 60(23):1–23. https://doi.org/10.1146/annurev-pharmtox-010919-023324
Aoyama T, Suzuki Y, Ichikawa H (1989) Neural networks applied to pharmaceutical problems.1. method and application to decision-making. Chem Pharm Bull 37:2558–2560. https://doi.org/10.1248/cpb.37.2558
Tetko IV, Villa AE, Aksenova TI, Zielinski WL, Brower J, Welsh WJ (1998) Application of a pruning algorithm to optimize artificial neural networks for pharmaceutical fingerprinting. J Chem Inf Comput Sci 38(4):660–668. https://doi.org/10.1021/ci970439j
Tetko IV, Villa AE, Livingstone DJ (1996) Neural network studies 2 variable selection. J Chem Inf Comput Sci 36(4):794–803. https://doi.org/10.1021/ci950204c
Agatonovic-Kustrin S, Beresford R (2000) Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research. J Pharm Biomed Anal 22(5):717–727. https://doi.org/10.1016/S0731-7085(99)00272-1
Gawehn E, Hiss JA, Schneider G (2016) Deep learning in drug discovery. Mol Inform 35:3–14. https://doi.org/10.1002/minf.201501008
Hinton G, Deng L, Yu D, Dahl GE, Mohamed AR, Jaitly N, Senior A, Vanhoucke V, Nguyen P, Sainath T, Kingsbury B (2012) Deep neural networks for acoustic modeling in speech recognition. IEEE Signal Proc Mag 29:82–97. https://doi.org/10.1109/MSP.2012.2205597
Silver D, Huang A, Maddison CJ, Guez A, Sifre L et al (2016) Mastering the game of Go with deep neural networks and tree search. Nature 529:484–489. https://doi.org/10.1038/nature16961
Ma J, Sheridan RP, Liaw A, Dahl GE, Svetnik V (2015) Deep neural nets as a method for quantitative structure-activity relationships. J Chem Inf Model 55:263–274. https://doi.org/10.1021/ci500747n
Mayr A, Klambauer G, Unterthiner T, Hochreiter S (2016) DeepTox: toxicity prediction using deep learning. Front Environ Sci 3:80. https://doi.org/10.3389/fenvs.2015.00080
Heffernan R, Paliwal K, Lyons J, Dehzangi A, Sharma A, Wang JH, Sattar A, Yang YD, Zhou YD (2015) Improving prediction of secondary structure, local backbone angles, and solvent accessible surface area of proteins by iterative deep learning. Sci Rep 5:11476. https://doi.org/10.1038/srep11476
Qian N, Sejnowski TJ (1988) Predicting the secondary structure of globular proteins using neural network models. J Mol Biol 202:865–884. https://doi.org/10.1016/0022-2836(88)90564-5
Qi YJ, Oja M, Weston J, Noble WS (2012) A unified multitask architecture for predicting local protein properties. PLoS ONE 7:e32235. https://doi.org/10.1371/journal.pone.0032235
Spencer M, Eickholt J, Cheng J (2015) A deep learning network approach to ab initio protein secondary structure prediction. IEEE/ACM Trans Comput Biol Bioinform 12(1):103–112. https://doi.org/10.1109/TCBB.2014.2343960
Wang S, Peng J, Ma JZ, Xu JB (2016) Protein secondary structure prediction using deep convolutional neural fields. Sci Rep 6:18962. https://doi.org/10.1038/srep18962
Jo T, Hou J, Eickholt J, Cheng J (2015) Improving protein fold recognition by deep learning networks. Sci Rep 5:17573. https://doi.org/10.1038/srep17573
Dill KA, Ozkan SB, Shell MS, Weikl TR (2008) The protein folding problem. Annu Rev Biophys 37:289–316. https://doi.org/10.1146/annurev.biophys.37.092707.153558
Dill KA, MacCallum JL (2012) The protein-folding problem, 50 years on. Science 338:1042–1046. https://doi.org/10.1126/science.1219021
Senior AW et al (2020) Improved protein structure prediction using potentials from deep learning. Nature 577:706–710. https://doi.org/10.1038/s41586-019-1923-7
Senior AW et al (2019) Protein structure prediction using multiple deep neural networks in the 13th critical assessment of protein structure prediction (CASP13). Proteins 87:1141–1148. https://doi.org/10.1002/prot.25834
Goshisht MK, Moudgil L, Rani M, Khullar P, Singh G, Kumar H, Singh N, Kaur G, Bakshi MS (2014) Lysozyme complexes for the synthesis of functionalized biomaterials to understand protein–protein interactions and their biological applications. J Phys Chem C 118(48):28207–28219. https://doi.org/10.1021/jp5078054
Goshisht MK, Moudgil L, Khullar P, Singh G, Kaura A, Kumar H, Kaur G, Bakshi MS (2015) Surface adsorption and molecular modeling of biofunctional gold nanoparticles for systemic circulation and biological sustainability. ACS Sustainable Chem Eng 3(12):3175–3187. https://doi.org/10.1021/acssuschemeng.5b00747
Khullar P, Goshisht MK, Moudgil L, Singh G, Mandial D, Kumar H, Ahliwalia GK, Bakshi MS (2017) Mode of protein complexes on gold nanoparticles surface: synthesis and characterization of biomaterials for hemocompatibility and preferential DNA complexation. ACS Sustainable Chem Eng 5(1):1082–1093. https://doi.org/10.1021/acssuschemeng.6b02373
Mahal A, Goshisht MK, Khullar P, Kumar H, Singh N, Kaur G, Bakshi MS (2014) Protein mixtures of environmentally friendly zein to understand protein–protein interactions through biomaterials synthesis, hemolysis, and their antimicrobial activities. Phys Chem Chem Phys 16:14257–14270. https://doi.org/10.1039/C4CP01457J
Scott DE, Bayly AR, Abell C, Skidmore J (2016) Small molecules, big targets: drug discovery faces the protein–protein interaction challenge. Nat Rev Drug Discov 15:533–550. https://doi.org/10.1038/nrd.2016.29
Santos R, Ursu O, Gaulton A, Bento AP, Donadi RS, Bologa CG, Karlsson A, Al- Lazikani B, Hersey A, Oprea TI, Overington JP (2017) A comprehensive map of molecular drug targets. Nat Rev Drug Discov 16:19–34. https://doi.org/10.1038/nrd.2016.230
Wilson AJ, Murphy NS, Long K, Azzarito V (2013) Inhibition of α-helix-mediated protein-protein interactions using designed molecules. Nat Chem 5:161–173. https://doi.org/10.1038/nchem.1568
Maheshwari S, Brylinski M (2016) Template-based identification of protein–protein interfaces using eFindSitePPI. Methods 93:64–71. https://doi.org/10.1016/j.ymeth.2015.07.017
Vakser IA (2014) Protein-protein docking: from interaction to interactome. Biophys J 107:1785–1793. https://doi.org/10.1016/j.bpj.2014.08.033
Mosca R, Ceol A, Aloy P (2013) Interactome3D: adding structural details to protein networks. Nat Methods 10:47–53. https://doi.org/10.1038/nmeth.2289
Du TC, Li L, Wu CH, Sun BL (2016) Prediction of residue-residue contact matrix for protein- protein interaction with Fisher score features and deep learning. Methods 110:97–105. https://doi.org/10.1016/j.ymeth.2016.06.001
Du XQ, Sun SW, Hu CL, Yao Y, Yan YT, Zhang YP (2017) DeepPPI: boosting prediction of protein-protein interactions with deep neural networks. J Chem Inf Model 57(6):1499–1510. https://doi.org/10.1021/acs.jcim.7b00028
Zenge H, Wanf S, Zhou TM, Zhao EF, Li XF, Wu Q, Xu JB (2018) ComplexContact: a web server for inter-protein contact prediction using deep learning. Nucleic Acids Res 46:W432–W437. https://doi.org/10.1093/nar/gky420
Xie Z, Deng X, Shu K (2020) Prediction of protein-protein interaction sites using convolutional neural network and improved data sets. Int J Mol Sci 221(2):467. https://doi.org/10.3390/ijms21020467
Rester U (2008) From virtuality to reality - Virtual screening in lead discovery and lead optimization: a medicinal chemistry perspective. Curr Opin Drug Discov Devel 11(4):559–568
Walters WP, Stahl MT, Murcko MA (1998) Virtual screening—an overview. Drug Discovery Today 3(4):160–178. https://doi.org/10.1016/S1359-6446(97)01163-X
Gonczarek A, Tomczak JM, Zareba S, Kaczmar J, Dabrowski P, Walczak MJ (2018) Interaction prediction in structure-based virtual screening using deep learning. Comput Biol Med 100:253–258. https://doi.org/10.1016/compbiomed.2017.09.007
Plewczynski D, Spieser SAH, Koch U (2009) Performance of machine learning methods for ligand-based virtual screening. Comb Chem High Throughput Screen 12(4):358–368. https://doi.org/10.2174/138620709788167962
Xiao T, Qi X, Chen YZ, Jiang Y (2018) Development of ligand-based big data deep neural network models for virtual screening of large compound libraries. Mol Inf 37:1800031. https://doi.org/10.1002/minf.201800031
Ferreira LG, Dos Santos RN, Oliva G, Andricopulo AD (2015) Molecular docking and structure-based drug design strategies. Molecules 20(7):13384–13421. https://doi.org/10.3390/molecules200713384
Akbar R, Jusoh SA, Amaro RE, Helms V (2017) ENRI: a tool for selecting structure based virtual screening target conformations. Chem Biol Drug Des 89:762–771. https://doi.org/10.1111/cbdd.12900
Bengio Y, Courville A, Vincent P (2013) Representation learning: a review and new perspectives. IEEE Trans Pattern Anal Mach Intell 35:1798–1828. https://doi.org/10.1109/TPAMI.2013.50
Pereira JC, Caffarena ER, dos Santos CN (2016) Boosting docking-based virtual screening with deep learning. J Chem Inf Model 56:2495–2506. https://doi.org/10.1021/acs.jcim.6b00355
Skalic M, Martínez-Rosell G, Jiménez J, De Fabritiis G (2019) PlayMolecule BindScope: large scale CNN-based virtual screening on the web. Bioinformatics 35:1237–1238. https://doi.org/10.1093/bioinformatics/bty758
Mendolia I, Contino S, Perricone U, Ardizzone E, Pirrone R (2020) Convolutional architectures for virtual screening. BMC Bioinformatics 21:310. https://doi.org/10.1186/s12859-020-03645-9
Esposito EX, Hopfinger AJ, Madura JD (2004) Methods for applying the quantitative structure-activity relationship paradigm. Methods Mol Biol 275:131–214. https://doi.org/10.1385/1-5259-802-1:131
Myint KZ, Xie XQ (2010) Recent advances in fragment-based QSAR and multidimensional QSAR methods. Int J Mol Sci 11:3846–3866. https://doi.org/10.3393/ijms/11103846
Lei T, Li Y, Song Y, Li D, Sun H, Hou T (2016) ADMET evaluation in drug discovery. Accurate prediction of rat oral acute toxicity using relevance vector machine and consensus modeling. J Cheminform 8: 6. https://doi.org/10.1186/s13321-016-0117-7
Aoyama T, Suzuki YJ, Ichikawa H (1990) Neural networks applied to quantitative structure-activity relationship analysis. J Med Chem 33:2583–2590. https://doi.org/10.1021/jm00171a037
Dong J, Yao ZJ, Zhu MF, Wang NN, Lu B, Chen AF, Lu AP, Miao HY, Zeng WB, Cao DS (2017) ChemSAR: an online pipelining platform for molecular SAR modeling. J Cheminform 9:27. https://doi.org/10.1186/s13321-0215-1
Dahl GE, Jaitly N, Salakhutdinov R (2014) Multi-task neural networks for QSAR predictions. 1–21. arXiv:https://arxiv.org/abs/1406.1231v1
Vina D, Uriarte E, Orallo F, González-Díaz H, (2009) Alignment-free prediction of a drug−target complex network based on parameters of drug connectivity and protein sequence of receptors. Mol Pharmaceutics 6:825–835. https://doi.org/10.1021/mp800102c
Prado-Prado FJ, Ubeira FM, Borges F, González-Díaz H, (2010) Unified QSAR & network-based computational chemistry approach to antimicrobials. II. multiple distance and triadic census analysis of antiparasitic drugs complex networks. J Comput Chem 31:164–173. https://doi.org/10.1002/jcc.21292
Speck-Planche A, Kleandrova VV, Luan F, Cordeiro MN (2012) Chemoinformatics in multi-target drug discovery for anti-cancer therapy: in silico design of Potent and versatile anti-brain tumor agents. Anticancer Agents Med Chem 12:678–685. https://doi.org/10.2174/187152012800617722
Tenorio-Borroto E, Penuelas-Rivas CG, Chagoyán JCV, Castañedo N, Prado-Prado FJ, García-Mera X, González-Díaz H (2012) ANN multiplexing model of drugs effect on macrophages; theoretical and flow cytometry study on the cytotoxicity of the anti-microbial drug G1 in spleen. Bioorg Med Chem 20:6181−6194. https://doi.org/10.1016/j.bmc.2012.07.020
Tenorio-Borroto E, García-Mera X, Penuelas-Rivas CG, Vasquez-Chagoyan JC, Prado-Prado FJ, Castanedo N, Gonzalez-Diaz H (2013) Entropy model for multiplex drug-target interaction endpoints of drug immunotoxicity. Curr Top Med Chem 13:1636–1649. https://doi.org/10.1016/j.ejmech.2013.08.035
Tenorio-Borroto E, Peñuelas-Rivas CG, Vásquez-Chagoyán JC, Castañedo N, Prado-Prado FJ, García-Mera X, González-Díaz H (2014) Model for high-throughput screening of drug immunotoxicity−study of the anti-microbial g1 over peritoneal macrophages using flow cytometry. Eur. J Med Chem 72:206−220. https://doi.org/10.1016/j.ejmech.2013.08.035
Speck-Planche A, Cordeiro MNDS (2013) Simultaneous modeling of antimycobacterial activities and ADMET profiles: a chemoinformatic approach to medicinal chemistry. Curr Top Med Chem 13:1656–1665. https://doi.org/10.2174/15680266113139990116
Speck-Planche A, Cordeiro MNDS (2017) Speeding up early drug discovery in antiviral research: a fragment-based in silico approach for the design of virtual anti-hepatitis C leads. ACS Comb Sci 19(8):501–512. https://doi.org/10.1021/acscombsci.7b00039
Ramsundar B, Kearnes S, Riley P, Webster D, Konerding D, Pande V (2015) Massively multitask networks for drug discovery. arXiv:https://arxiv.org/abs/1502.02072v1
Xu Y, Ma J, Liaw A, Sheridan RP, Svetnik V (2017) Demystifying multitask deep neural networks for quantitative structure−activity relationships. J Chem Inf Model 57(10):2490–2504. https://doi.org/10.1021/acs.jcim.7b00087
Koutsoukas A, Monaghan KJ, Li X, Huan J (2017) Deep-Learning: investigating deep neural networks hyper-parameters and comparison of performance to shallow methods for modeling bioactivity data. J Cheminformatics 9:42. https://doi.org/10.1186/s13321-017-0226-y
Mendenhall J, Meiler J (2016) Improving quantitative structure−activity relationship models using artificial neural networks trained with dropout. J Comput-Aided Mol Des 30:177–189. https://doi.org/10.1007/s10822-016-9895-2
Shahriari B, Swersky K, Wang Z, Adams RP, De Freitas N (2016) Taking the human out of the loop: a review of Bayesian optimization. Proc IEEE 104:148–175. https://doi.org/10.1109/JPROC.2015.2494218
Zhao Z, Qin J, Gou Z, Zhang Y, Yang Y (2020) Multi-task learning models for predicting active compounds. J Biomed Inform 108:103484. https://doi.org/10.1016/j.jbi.2020.103484
Kharkar PS (2010) Two-dimensional (2D) in silico models for absorption, distribution, metabolism, excretion and toxicity (ADME/T) in drug discovery. Curr Top Med Chem 10:116–126. https://doi.org/10.2174/1568026.10790232224
Wang YL, Xing J, Xu Y, Zhou NN, Peng JL, Xiong ZP, Liu X, Luo XM, Luo C, Chen KX, Zheng MY, Jiang HL (2015) In silico ADME/T modelling for rational drug design. Q Rev Biophys 48:488–515. https://doi.org/10.1017/s0033583515000190
Xue HQ, Li J, Xie HZ, Wang YD (2018) Review of drug repositioning approaches and resources. Int J Biol Sci 14:1232–1244. https://doi.org/10.7150/ijbs.24612
Kennedy T (1997) Managing the drug discovery/development interface. Drug Discov Today 2:436–444. https://doi.org/10.1016/s1359-6446(97)01099-4
Merlot G (2010) Computational toxicology-a tool for early safety evaluation, Drug Discov. Today 15:16–22. https://doi.org/10.1016/j.drudis.2009.09.010
Khanna I (2012) Drug discovery in pharmaceutical industry: productivity challenges and trends. Drug Discov Today 17:1088–1102. https://doi.org/10.1016/j.drudis.2012.05.007
Tan JJ, Cong XJ, Hu LM, Wang CX, Jia L, Liang XJ (2010) Therapeutic strategies underpinning the development of novel techniques for the treatment of HIV infection. Drug Discov Today 15:186–197. https://doi.org/10.1016/j.drudis.2010.01.004
Kortagere S, Chekmarev DS, Welsh WJ, Ekins S (2008) New predictive models for blood-brain barrier permeability of drug-like molecules. Pharm Res 25:1836–1845. https://doi.org/10.1007/s11095-0008-9584-5
Obrezanova O, Csanyi G, Gola GMR, Segall MD (2007) Gaussian processes: a method for automatic QSAR modeling of ADME properties. J Chem Inf Model 47(5):1847–1857. https://doi.org/10.1021/ci7000633
Lombardo F, Obach RS, DiCapua FM, Bakken GA, Lu J, Potter DM, Gao F, Miller MD, Zhang Y (2006) A hybrid mixture discriminant analysis-random forest computational model for the prediction of volume of distribution of drugs in human. J Med Chem 49:2262–2267. https://doi.org/10.1016/j.drudis.2017.08.010
Klon AE, Lowrie JF, Diller DJ (2006) Improved naive Bayesian modeling of numerical data for absorption, distribution, metabolism and excretion (ADME) property prediction. J Chem Inf Model 46:1945–1956. https://doi.org/10.1021/ci0601315
Clark AM, Dole K, Coulon-Spektor A, McNutt A, Grass G, Freundlich JS, Reynolds RC, Ekins S (2015) Open source bayesian models. 1. application to ADME/Tox and drug discovery datasets. J Chem Inf Model 55:1231–1245. https://doi.org/10.1021/acs.jcim.5b00143
Li X, Xu Y, Lai L, Pai J (2018) Prediction oh human cytochrome P450 inhibition using a multitask deep autoencoder neural network. Mol Pharmaceutics 15(10):4336–4345. https://doi.org/10.1021/acs.molpharmaceut.8b00110
Ramsundar B, Liu B, Wu Z, Verras A, Tudor M, Sheridan RP, Pande V (2017) Is multitask deep learning practical for pharma? J Chem Inf Model 57:2068–2076. https://doi.org/10.1021/acs.jcim.7b00146
Altae-Tran H, Ramsundar B, Pappu AS, Pande V (2017) Low data drug discovery with one-shot learning. ACS Cent Sci 3:283–293. https://doi.org/10.1021/acscentsci.6b00367
Wenlock MC, Carlsson LA (2015) How experimental errors influence drug metabolism and pharmacokinetic QSAR/QSPR models. J Chem Inf Model 55:125–134. https://doi.org/10.1021/ci500535s
Wenzel J, Matter H, Schmidt F (2019) Predictive multitask deep neural network models for ADME-Tox properties: learning from large data sets. J Chem Inf Model 59(3):1253–1268. https://doi.org/10.1021/acs.jcim.8b00785
Hughes TB, Miller GP, Swamidass SJ (2015) Modeling epoxidation of drug-like molecules with a deep machine learning network. ACS Cent Sci 1:168–180. https://doi.org/10.1021/acscentsci.5b00131
Xu YJ, Dai ZW, Chen FJ, Gao SS, Pei JF, Lai LH (2015) Deep learning for drug induced liver injury. J Chem Inf Model 55:2085–2093. https://doi.org/10.1021/acs.jcim.5b00238
Novac N (2013) Challenges and opportunities of drug repositioning. Trends Pharmacol Sci 34:267–272. https://doi.org/10.1016/j.tips.2013.03.004
Tripathi N, Tripathi N, Goshisht MK (2021) COVID-19: inflammatory responses, structure-based drug design and potential therapeutics. Mol Divers. https://doi.org/10.1007/s11030-020-10176-1
Chen X, Yan CC, Zhang XT, Zhang X, Dai F, Yin J, Zhang YD (2016) Drug–target interaction prediction: databases, web servers and computational models. Briefings Bioinf 17:696–712. https://doi.org/10.1093/bib/bbv066
Romero Durán FJ, Alonso N, Caamaňo O, García-Mera X, Yaneez M, Prado-Prado FJ, Gonz_alez-Díaz H (2014) Prediction of multi-target networks of neuroprotective compounds with entropy indices and synthesis, assay, and theoretical study of new asymmetric, 1,2-rasagiline carbamates. Int J Mol Sci 15:17035–17064. https://doi.org/10.3390/ijms150917035
Kitchen DB, Decornez H, Furr JR, Bajorath J (2004) Docking and scoring in virtual screening for drug discovery: methods and applications. Nat Rev Drug Discov 3:935–949. https://doi.org/10.1038/nrd1549
Yao ZJ, Dong J, Che YJ, Zhu MF, Wen M, Wang NN, Wang S, Lu AP, Cao DS (2016) TargetNet: a web service for predicting potential drug-target interaction profiling via multi-target SAR models. J Comput Aided Mol Des 30:413–424. https://doi.org/10.1007/s10822-016-9915-2
Zhou Y, Wang F, Tang J, Nussinov R, Cheng F (2020) Artificial intelligence in COVID-19 drug repurposing. The Lancet Digital Health 2(12):E667–E676. https://doi.org/10.1016/S2589-7500(20)30192-8
Wen M, Zhang ZM, Niu SY, Sha HZ, Yang RH, Yun YH, Lu HM (2017) Deep learning- based drug-target interaction prediction. J Proteome Res 16:1401–1409. https://doi.org/10.1021/acs.jproteome.6b00618
Luo YL, Zhao XB, Zhou JT, Yang JL, Zhang YQ, Kuang WH, Peng J, Chen L, Zeng JY (2017) A network integration approach for drug-target interaction prediction and computational drug repositioning from heterogeneous information. Nat Commun 8:573. https://doi.org/10.1021/acs.jproteome.6b00618
Schneider G, Fechner U (2005) Computer-based de novo design of drug-like molecules. Nat Rev Drug Discov 4:649–663. https://doi.org/10.1038/nrd1799
Böhm HJ (1992) The computer program LUDI: a new method for the de novo design of enzyme inhibitors. J Comput Aided Mol Des 6:61–78. https://doi.org/10.1007/bf00124387
Schneider G, Geppert T, Hartenfeller M, Reisen F, Klenner A, Reutlinger M, Hähnke V, Hiss JA, Zettl H, Keppner S, Spänkuch B, Schneider P (2011) Reaction-driven de novo design, synthesis and testing of potential type II kinase inhibitors. Future Med Chem 3:415–424. https://doi.org/10.4155/fmc.11.8
Gόmez-Bombarelli R, Wei JN, Duvenaud D, Hernández-Lobato JM, Sánchez-Lengeling B, Sheberla D, Aguilera-Iparraguirre J, Hirzel TD, Adams RP, Aspuru-Guzik A (2018) Automatic chemical design using a data-driven continuous representation of molecules. ACS Cent Sci 4(2):268–276. https://doi.org/10.1021/acscentsci.7b00572
Skalic M, Jimėnez J, Sabbadin D, De Fabritiis F (2019) Shape-based generative modeling for de novo drug design. J Chem Inf Model 59:1205–1214. https://doi.org/10.1021/acs.jcim.8b00706
Collins KD, Glorius FA (2013) Robustness screen for the rapid assessment of chemical reactions. Nat Chem 5:597–601. https://doi.org/10.1038/nchem.1669
Wei JN, Duvenaud D, Aspuru-Guzik A (2016) Neural networks for the prediction of organic chemistry reactions. ACS Cent Sci 2:725−732.
Huang Q, Li L-L, Yang S-Y (2011) RASA: a rapid retrosynthesis-based scoring method for the assessment of synthetic accessibility of drug-like molecules. J Chem Inf Model 51:2768–2777. https://doi.org/10.1021/ci100216g
Fialkowski M, Bishop KJ, Chubukov VA, Campbell CJ, Grzybowski BA (2005) Architecture and evolution of organic chemistry. Angew Chem Int Ed 44:7263–7269.
Peplow M (2014) Organic synthesis: the robo-chemist. Nature 512:20–22. https://doi.org/10.1038/512020a
Gothard CM, Soh S, Gothard NA, Kowalczyk B, Wei Y, Baytekin B, Grzybowski BA (2012) Rewiring chemistry: algorithmic discovery and experimental validation of one-pot reactions in the network of organic chemistry. Angew Chem Int Ed 51:7922–7927. https://doi.org/10.1002/anie.201202155
Kowalik M, Gothard CM, Drews AM, Gothard NA, Weckiewicz A, Fuller PE, Grzybowski BA, Bishop KJ (2012) Parallel optimization of synthetic pathways within the network of organic chemistry. Angew Chem Int Ed 51:7928–7932. https://doi.org/10.1002/anie.201202209
Coley CW, Barzilay R, Jaakkola TS, Green WH, Jensen KF (2017) Prediction of organic reaction outcomes using machine learning. ACS Cent Sci 3:434–443. https://doi.org/10.1021/acscentsci.7b0006.4
Lowe DM (2012) Extraction of chemical structures and reactions from the literature. Doctoral dissertation, University of Cambridge 1289. https://doi.org/10.17863/CAM.16293.
Segler MH, Waller MP (2017) Neural-symbolic machine learning for retrosynthesis and reaction prediction. Chem Eur J 23:5966–5971. https://doi.org/10.1002/chem.201605499
Segler MH, Preuss M, Waller MP (2018) Planning chemical syntheses with deep neural networks and symbolic AI. Nature 555:604–610. https://doi.org/10.1038/nature25978
Browne CB, Powley E, Whitehouse D, Lucas SM, Cowling PI, Rohlfshagen P, Tavener S, Perez D, Samothrakis S, Colton SA (2012) Survey of monte carlo tree search methods. IEEE Trans Comput Intell AI Games 4:1–43. https://doi.org/10.1109/TCIAIG.2012.2186810
Segler MH, Waller MP (2017) Modelling chemical reasoning to predict and invent reactions. Chem- Eur J 23:6118–6128. https://doi.org/10.1002/chem.201604556
Mamoshina P, Vieira A, Putin E, Zhavoronkov A (2016) Applications of deep learning in biomedicine. Mol Pharm 13:1445–1454. https://doi.org/10.1021/acs.molpharmaceut.5b00982